Testing effectiveness (Phase 2)Looking for participantsNCT06330064
What this trial is testing
Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Who this might be right for
Recurrent or Metastatic Solid Tumors
Daiichi Sankyo 680